Dallas, TX (PRWEB) June 28, 2014
Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) – Global Forecast to 2019 research report discusses the key market drivers, restraints, and opportunities in the global metabolomics market and its sub-markets. The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibit the growth of the market to a certain extent. Complete report is available at http://www.lifescienceindustryresearch.com/metabolomics-market-by-technique-gas-chromatography-high-performance-liquid-chromatography-nuclear-magnetic-resonance-spectroscopy-mass-spectrometry-application-biomarker-drug-discovery-nutr.html.
During the forecast period, the high performance liquid chromatography (HPLC) segment will continue to drive and dominate the metabolomics market. The large share of the HPLC segment can be attributed to its wide application in biomarker discovery. By 2018, North America will continue to drive and dominate the metabolomics market, primarily due to the presence of major metabolomics companies in the U.S. Majority of the growth in the Asia-Pacific region is primarily driven by the growing pharmaceutical and biotechnology industries in this region. Developing technologies in Japan and China for drug discovery and early diagnosis of various diseases are expected to aid the growth of the APAC metabolomics market.
Thermo Fisher Scientific, Inc. (U.S.) and Danaher Corporation (U.S.) are the leading players in the market which together accounted for a share of around 40% to 45% in 2013. Thermo Fisher Scientific has a diversified product portfolio, which includes a wide range of analytical products, including liquid chromatography and gas chromatography systems. The company has a strong presence in over 150 countries through its strong manufacturing and distribution facilities, which enables it to cater to a large customer base across the globe. It focuses on strengthening and streamlining its product portfolio for the metabolomics market.
Companies profiled in this metabolomics market research report include Agilent Technologies, Biocrates Life Sciences AG, Bruker Corporation, Danaher Corporation, Human Metabolomics Technologies, Inc., LECO Corporation, Metabolon, Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc (Life Technologies + Prionics AG) and Waters Corporation. Order a copy of this report at http://www.lifescienceindustryresearch.com/purchase?rname=15640.
Reasons to Buy the Report
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping a greater market share. This report provides insights on the following pointers:
Another report says the global breast imaging technologies market is estimated to grow at a CAGR of 8.1% from 2014 to 2019. This report titled Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) – Global Forecasts to 2019 is available at http://www.lifescienceindustryresearch.com/breast-imaging-technologies-market-digital-mammography-3d-breast-tomosynthesis-breast-mri-breast-ultrasound-molecular-breast-imaging-optical-imaging-petctpem-modalities-technology-and-marke.html .
NewBorn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019 research report says mass spectrometry market is expected to register the highest growth rate in the newborn screening market by technology, during the forecast period. This high growth is attributed to various nations opting for expanded newborn screening. Tandem mass spectrometry is a fundamental instrument used for expanded newborn screening. Furthermore, various conferences and symposiums are being conducted to spread awareness for the use of such technologies. Complete report is available at http://www.lifescienceindustryresearch.com/newborn-screening-market-by-test-type-dried-blood-spot-hearing-screening-cchd-technology-tandem-mass-spectrometry-immunoassay-enzyme-assay-electrophoresis-pulse-oximeter-instrument-access.html .
Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories. Contact us ( sales(at)lifescienceindustryresearch(dot)com / + 1 888 391 5441) for any of your research requirements or topics of interest. Our sales & research associates will be happy to help you find relevant market data.